Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hesham Abboud

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Neurology|July 3, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practiceHesham Abboud, Brian Steingo, Diana Vargas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 2, 2021
Autoimmune encephalitis: proposed recommendations for symptomatic and long-term managementHesham Abboud, John Probasco, Sarosh R Irani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 2, 2021
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute managementHesham Abboud, John C Probasco, Sarosh Irani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Neurology|July 3, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practiceHesham Abboud, Brian Steingo, Diana Vargas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 2, 2021
Autoimmune encephalitis: proposed recommendations for symptomatic and long-term managementHesham Abboud, John Probasco, Sarosh R Irani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 2, 2021
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute managementHesham Abboud, John C Probasco, Sarosh Irani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum DisorderJoao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Pageof 7